VIR BIOTECHNOLOGY, INC revenue breakdown overview

VIR BIOTECHNOLOGY, INC revenue for the last year amounted to 1.46 B MXN, the most of which — 1.46 B MXN — came from its highest performing source at the moment, Antibody-based Therapies, the year earlier bringing 31.52 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought VIR BIOTECHNOLOGY, INC 1.46 B MXN, and the year before that — 31.52 B MXN.